154 related articles for article (PubMed ID: 11863479)
21. Osteoporosis risk and low bone mineral density in women with physical disabilities.
Smeltzer SC; Zimmerman V; Capriotti T
Arch Phys Med Rehabil; 2005 Mar; 86(3):582-6. PubMed ID: 15759248
[TBL] [Abstract][Full Text] [Related]
22. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
23. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.
Stone KL; Seeley DG; Lui LY; Cauley JA; Ensrud K; Browner WS; Nevitt MC; Cummings SR;
J Bone Miner Res; 2003 Nov; 18(11):1947-54. PubMed ID: 14606506
[TBL] [Abstract][Full Text] [Related]
24. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
25. Clinical use of bone densitometry: scientific review.
Cummings SR; Bates D; Black DM
JAMA; 2002 Oct; 288(15):1889-97. PubMed ID: 12377088
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: A registry-based cohort study.
Leslie WD; Seeman E; Morin SN; Lix LM; Majumdar SR
Bone; 2018 Sep; 114():298-303. PubMed ID: 30008396
[TBL] [Abstract][Full Text] [Related]
27. Interventions to increase osteoporosis treatment in patients with 'incidentally' detected vertebral fractures.
Majumdar SR; McAlister FA; Johnson JA; Bellerose D; Siminoski K; Hanley DA; Qazi I; Lier DA; Lambert RG; Russell AS; Rowe BH
Am J Med; 2012 Sep; 125(9):929-36. PubMed ID: 22938928
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.
Vanasse A; Dagenais P; Niyonsenga T; Grégoire JP; Courteau J; Hemiari A
BMC Musculoskelet Disord; 2005 Jun; 6():33. PubMed ID: 15969760
[TBL] [Abstract][Full Text] [Related]
30. Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care.
Saadi H; Litaker D; Mills W; Kippes C; Richmond B; Licata A
J Womens Health Gend Based Med; 1999; 8(6):767-71. PubMed ID: 10495258
[TBL] [Abstract][Full Text] [Related]
31. Prevention of osteoporosis and fractures.
Ullom-Minnich P
Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
[TBL] [Abstract][Full Text] [Related]
32. Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women.
Lee E; Zuckerman IH; Weiss SR
Arch Intern Med; 2002 Nov; 162(20):2362-6. PubMed ID: 12418951
[TBL] [Abstract][Full Text] [Related]
33. Follow-up for osteoporosis in older patients three years after a fracture.
Schurink M; Hegeman JH; Kreeftenberg HG; Ten Duis HJ
Neth J Med; 2007 Feb; 65(2):71-4. PubMed ID: 17379932
[TBL] [Abstract][Full Text] [Related]
34. Adherence of academic geriatric practitioners to osteoporosis screening guidelines.
McNally DN; Kenny AM; Smith JA
Osteoporos Int; 2007 Feb; 18(2):177-83. PubMed ID: 17043904
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
[TBL] [Abstract][Full Text] [Related]
36. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Reginster JY; Felsenberg D; Pavo I; Stepan J; Payer J; Resch H; Glüer CC; Mühlenbacher D; Quail D; Schmitt H; Nickelsen T
Osteoporos Int; 2003 Sep; 14(9):741-9. PubMed ID: 12827224
[TBL] [Abstract][Full Text] [Related]
37. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
Blalock SJ; Norton LL; Patel RA; Dooley MA
Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women.
Pinheiro MM; Reis Neto ET; Machado FS; Omura F; Yang JH; Szejnfeld J; Szejnfeld VL
Rev Saude Publica; 2010 Jun; 44(3):479-85. PubMed ID: 20549019
[TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of osteoporosis in women with breast cancer.
Mincey BA; Moraghan TJ; Perez EA
Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
[TBL] [Abstract][Full Text] [Related]
40. The American Orthopaedic Association's "own the bone" initiative to prevent secondary fractures.
Tosi LL; Gliklich R; Kannan K; Koval KJ
J Bone Joint Surg Am; 2008 Jan; 90(1):163-73. PubMed ID: 18171971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
